FindTrial
Sign In

A clinical study to identify the low glycemic index millet foods and their effect in people with diabetes to know the health benefits

A clinical study to assess the In-vivo Glycemic Index of millet foods and their effect on HbA1c in people with type-2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048104
Enrollment
100
Registered
2022-12-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Experimental Group: Feeding 8 millet based food to 12-15 healthy individuals for 3 months duration Control Intervention1: Reference: Feeding Reference food (Glucose) equivalent to 50g o

Sponsors

ICARIndian Institute of Millets Research
Lead Sponsor
FS Endocrinology and Diabetic Center Hyderabad
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Part A : Asses In-vivo Glycemic Index of millet foods Inclusion criteria Healthy non-diabetic subjects (male & female) Age: 19-39 years BMI: 18.5-23.5 kg/ m2 Fasting blood glucose level Part B : Testing the identified low glycemic index millet foods in people with Diabetes

Exclusion criteria

Exclusion criteria: Part A : Asses In-vivo Glycemic Index of millet foods Exclusion Criteria: Subjects with food allergy, chronic disease or on medication Pregnant/ lactating women Smokers Consuming > 2 alcohol servings per week Part B : Testing the identified low glycemic index millet foods in people with Diabetes Exclusion Criteria: Subjects with food allergy, Gastro-intestinal disorders or on medication for other comorbidities Pregnant/ lactating women Smokers Consuming > 2 alcohol servings per week

Design outcomes

Primary

MeasureTime frame
Reliable data on glycemic index and glycemic load of millet foods and benefits of low glycemic index millet food in people with type 2 diabetesTimepoint: 12 months—

Secondary

MeasureTime frame
N/ATimepoint: N/A—

Countries

India

Contacts

Public ContactDr Venkateswarlu Ronda

FS Endocrinology and Diabetic Center, Hyderabad

drfarazfarishta@gmail.com09885035977

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026